Home
Explore
Journal Club
Trending
More
Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Language
English
English
TA
Timothy A. Chan
Cancer Immunotherapy and Biomarkers
Seattle Children's Hospital
Share
Follow
Claim This Profile
About
Research focus
Cancer Immunotherapy and Biomarkers
Impact
1,023 pubs · 110,205 cites · h-index 131
Affiliations
Seattle Children's Hospital
Cleveland Clinic
Memorial Sloan Kettering Cancer Center
See all
Publications
Recent publications by Timothy A. Chan
Quantum convolutional HLA immunogenic peptide prediction (Q-CHIPP): Next-generation neoantigen prediction with quantum neural network
Science Advances · Fri,
Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPG
Clinical Cancer Research · Tue,
Hypoxia shapes both therapeutic response and resistance in metastatic clear cell renal cell carcinoma
Cancer Cell · Mon,
Novel Mechanism of and Therapeutic Approach for Anthracycline-Induced Cardiotoxicity (AIC)
Cancer Research Communications · Fri,
Neural cell state modulation by PARK2 and dopaminergic neuroprotection by small molecule Parkin agonism
Sat,
The SLC1A1/EAAT3 dicarboxylic amino acid transporter is an epigenetically dysregulated nutrient carrier that sustains oncogenic metabolic programs
Nature Communications · Fri,
34Hypoxia and immune suppression shapes therapeutic outcomes and metastases in clear cell renal cell carcinoma
The Oncologist · Wed,
62The SLC1A1/EAAT3 dicarboxylic amino acid transporter is an epigenetically dysregulated nutrient carrier that sustains oncogenic metabolic programs
The Oncologist · Wed,
MCL1 may not mediate chemoresistance
Wed,
Inhibition of KDEL receptors remodels the tumor microenvironment for robust T cell independent tumor regression
Mon,